Physician profile
Michael Lebhar
NPI 1871128223
$7,690.42
in general payments reported to CMS, 2019-2025
25 companies · $1,949 in 2025
The $1,949 reported for 2025 was more than what 83% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $651 · 2022: $1,262 · 2023: $2,013 · 2024: $1,817 · 2025: $1,949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,778.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,064.67 | 2022-2025 | Integra, Tenoglide, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $1,039.27 | 2021-2025 | Na, Matrixmandible |
| Kerecis Limited | $987.58 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $678.85 | 2021-2025 | Na, Vsp System, Vsp Cranial, Delta |
| Access Pro Medical, LLC | $458.96 | 2022-2023 | Matriderm |
| Davol INC. | $458.78 | 2024-2025 | Phasix Mesh, Arista Ah Flexitip |
| Kls-Martin L.P. | $385.50 | 2021-2023 | |
| Rti Surgical, INC | $340.35 | 2024-2025 | |
| Tela Bio, INC. | $292.55 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Baxter Healthcare | $275.96 | 2021-2023 | |
| Somavac Medical Solutions, INC. | $257.60 | 2022-2024 | Somavac 100 Sustained Vacuum System |
| Revance Therapeutics, INC. | $255.89 | 2025 | Daxxify |
| Sonex Health, INC. | $213.59 | 2022 | |
| Axogen | $151.48 | 2025 | |
| Becton, Dickinson and Company | $140.77 | 2025 | Phasix Mesh |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $134.19 | 2024 | Irrisept |
| Allergan, INC. | $125.00 | 2021 | |
| Endo Pharmaceuticals INC. | $123.86 | 2023 | Xiaflex |
| Abbvie INC. | $96.97 | 2023-2025 | |
| Motiva USA, LLC | $75.00 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $68.25 | 2024 | |
| Medline Industries LP | $21.36 | 2023 | |
| Sanara Medtech INC. | $18.08 | 2022 | |
| Solventum Corporation | $16.05 | 2024 | Prevena |
| Medela LLC | $9.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lebhar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.